SAN JOSE, Calif.--(BUSINESS WIRE)--VSee Health, Inc. (Nasdaq: VSEE) a leading provider of HIPAA-compliant digital health solutions has been selected to support a NIH-funded Phase 3 clinical trial ...
Zacks Investment Research on MSN
Veeva unveils AI study builder agent to speed clinical trial setup
Veeva Systems VEEV recently introduced Veeva Study Builder Agent, a new AI-powered solution designed to accelerate clinical ...
The Global Clinical Trials Market was valued at USD 58.19 Billion in 2025 and is projected to grow at a 6.13% CAGR from 2026 to 2034, reaching USD 99.4 Billion by 2034, according to Maximize Market ...
Despite being a cornerstone of cancer treatment advancement, clinical trials remain inaccessible for many patients because of structural, socioeconomic, and systemic barriers. In this ...
The Global AI in Clinical Trials Market was valued at USD 2 Billion in 2025 and is projected to grow at a 15.5% CAGR from 2026 to 2034, reaching USD 7.32 Billion by 2034, according to Maximize Market ...
Racial/Ethnic Disparities in Hospitalization Outcomes by Palliative Care Utilization and Trends Among Women With Metastatic Breast Cancer in the United States US-based phase I-III cancer treatment ...
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...
Clinical trials test new methods of finding, treating, and preventing cancer. They also help doctors improve the quality of life for people with cancer. Today, people are living longer lives thanks to ...
What Are Clinical Trials for MASH? Clinical trials for MASH are research studies that evaluate potential new treatments for a form of liver disease called metabolic dysfunction-associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results